Introduction: Neuroglobin (Ngb) owes its name to its preferred location in the nervous system. Its plasma concentration increases during cerebral ischemia. However, the interest of its dosage in the diagnosis and the prognosis of the strokes in the adult is not defined. Objectives: To determine if plasmatic Ngb can be used as a diagnostic biomarker and prognostic for stroke in adults at the acute phase. Population and Methods: This was a prospective study in 69 people, including 39 suspected stroke (Cerebral ischemia or CI, Intracerebral hemorrhage or ICH) and 30 healthy volunteers (controls). The plasma concentration of Ngb (CmNgb in ng/ml) of the patients was determined at admission day (d1), at the third day (d3) and seventh day (d7). CmNgbtaken at d1 was compared between patients and controls. Its evolution over time, as well as its relation with the clinical parameters, including the Glasgow coma scale and the short-term mortality in stroke subjects was analyzed by the Mann and Whitney tests and the Wilcoxon test (p < 0.05). Results: At d1, the CmNgb of all types of stroke was 3.140 ± 2.700 ng/ml, and did not differ significantly from controls (0.303 ± 0.114 ng/ml, p = 0.070). On the other hand, it was higher in CI victims (5.800 ± 0.720 ng/ml) than in ICH (1.750 ± 0,090 ng/ml) (p = 0.030). It then decreased on d3 in CI victims (2.600 ± 0.112 ng/ml) and ICH (0.420 ± 0.211 ng/ml), returning to normal on d7 (0.420 ± 0.200 ng/ml for CI's, p = 0.001, and 0.360 ± 0.300 ng/ml for ICH, p = 0.002). There was a relationship between CmNgb, delay of How to cite this paper: Nnang Essone, J.F., Allognon, C., Nkiema, R., Aubin Igombé, S.R., Nzoghe Nguema, P., Ovono Abessolo, F., Anyunzok, E. and Ngou Milama, E. occurrence of the first symptoms of the stroke (3.140 ± 2.700 ng/ml before the 6th hour, and 0.643 ± 0.244 ng/ml after the 6th hour (p = 0.003) and the volume of the hematoma (p = 0.0027). None relationship existed between CmNgb, Glasgow coma scale (p = 0.427) and short-term mortality (CmNgb = 3.95 ng/ml in survivors versus 2.65 ng/ml in deceased p = 0.060). Conclusion: This study shows that the plasma concentration of Neuroglobin is high during stroke in humans in the acute phase. This elevation follows triphasic kinetics and appears to be more important during infarction than hemorrhage. These results suggest that CmNgb can be used as a diagnostic marker for stroke in adult at the acute phase, by differentiating ischemia from hemorrhage. However, this work needs to be confirmed on a larger sample of patients.
Introduction
Neuroglobin (Ngb) is a protein discovered in 2000 by Burmester et al. [1] [2] . It owes its name because of its preferential expression in the nervous system [1] [2] [3] . It is a protein that derives from an old branch of globin more than 600 million years ago [1] [2] . Ngb was initially identified from the nucleic databases of mouse and human brains [1] . At present, the exact biological functions of Ngb as well as its mechanisms of action remain poorly known. However, by the fact that its plasma concentration increases of hypoxia situation [1] - [10] , especially of cerebral [1] [19] and anti-apoptotic effect [20] [21] are particularly noteworthy. One of the mechanisms involved in these processes seems to be in relation by mitochondrial oxidation pathways, the regulation of which would be via hypoxia inducible factor-1 alpha (HIF-1 alpha) [1] [22] .
As part of neuroprotection during acute cerebral infarction, Ngb has been widely evaluated from other vertebrates, but very little in humans [13] [23] [24] [25] [26] [27] . Indeed, in rodents, it has been shown that stroke induced after carotid occlusion is responsible for high plasmatic concentration of Ngb. The authors suggested a role of diagnostic biomarker and monitoring of this protein during acute stroke [1] [2] [3] [13] . In the human, two studies done by Jin et al in 2010 and 2013 had noted overexpression of Ngb, respectively in infarcted area of CI, and in peri-hematoma area during ICH secondary to a rupture of venous arterial malformations. According to them, these results supported the neuroprotective role of Ngb during ischemic events in the central nervous system, including stroke [13] [23] [24] [25] [26] [27] . Stroke (Cerebral infarction or CI, and intracerebral hemorrhage or ICH) is a common pathology in Africa World Journal of Neuroscience [28] - [33] . It may be complicated by hypoxia and/or focal or general cerebral ischemia, whether acute or secondary depending on the type and severity. Inflammatory phenomena associated with the apoptosis process in infarcted and peri-infarcted zones have been described [34] [35] [36] . Currently, brain imaging remains the best way for diagnosis, therapeutic, monitoring and prognosis [34] [35] [36] [37] . In recent years, several research teams have been working on the demonstration of biomarkers which, in support of brain imaging techniques, would allow a much faster diagnosis, but above all more precise in terms of etiopathogenesis and pathophysiology. However, most of these studies have not yet resulted in consensus [38] [39] [40] [41] . Also, we wondered whether Ngb could be a biological marker, in addition to clinical examination and medical imaging, for the initial diagnosis and prognosis for stroke in adult at the acute phase.
Population and Methods

Population
This was a prospective study, conducted in Libreville (Gabon), from January 2016 to January 2017 included. The recruitment of people suffering from stroke (anamnesis, general examination, neurological, brain scan) was carried out in the emergency, resuscitation and neurology departments of the main university hospitals in Libreville. Volunteers (healthy people or controls), after anamnesis, general and neurological examination were selected from the general population in voluntary mode. The neuroglobin assay was done at the biochemistry laboratory of the Libreville University of Health Sciences. This investigation was conducted taking into account the principles of medical ethics according to the Helsinki Declaration [42] . The authorizations of the responsibilities in charge of the units in which the study had been carried out were obtained. In addition, volunteers and parents of patients were assured of the confidentiality of the data collected.
Methods
Recruitment of the Study Population
Upon admitted to the different departments (resuscitation or neurology) for suspicion of stroke, the patients had a clinical examination (anamnesis, general and neurological examination) carried out by a neurologist and a resuscitator. This evaluation made it possible to look for the clinical signs in favor of a stroke [34] , and subsequently to establish the prognostic scores such as, the Glasgow coma scale according to Teasdale and Jennet [44] , the Four score (Full out line of unresponsiveness score) developed by Wijdicks et al. [45] , and the score of the World Federation of Neurosurgical Societies (WFNS score) [46] . For the plasmatic dosage of Ngb, blood samples were taken from the veins of the forearm on ethylene thiamine tetra acetic tube (EDTA), for a volume of 5 ml of blood per tube. The blood tests were performed at admission (d1), concomitantly with the routine checkup (blood count, blood ionogram, uremia, serum creatinine, serum uric acid, blood glucose, prothrombin time and activated cephalin time), at the third (d3) and seventh day (d7 , subarachnoid hemorrhage or SAH), and the establishment of specific gravity scores for stroke (Fisher [47] and Hemphill JC scores [48] ). Short-term mortality was determined during the first seven days of hospitalization for all patients selected for the study.
The volunteers were recruited consecutively, by direct matching with patients, according to age and sex. Once verbal agreement obtained with each of them, an appointment was given to them in one of the pre-anesthesia consultation rooms of the University Hospital of Libreville for the clinical evaluation (Anamnesis, general and neurological examination) and the blood sample. Instead of the appointment, after signature of the consent, a single blood test was made at a peripheral vein of the forearm, in the same way as the patients. The blood, after being taken from an EDTA tube, was then sent to the Faculty of Medicine's Biochemistry Laboratory where it was conditioned and stored using the same procedures as in patients.
In all participants, the data from the clinical and paraclinical evaluation were subsequently recorded in a medical file. In the stroke, these were epidemiological (age in year, gender, history of hypertension), clinicals (delay presumed occurrence of the first symptoms of stroke, especially, occurrence before the 6th hour, or after 6th hour following hospitalization), paraclinics (type and nature of World Journal of Neuroscience stroke using cerebral CT, i.e. ICH ; the plasma concentration of Ngb in ng/ml and its kinetics during the first seven days of hospitalization by the determination of Ngb at d1, d3 and d7), as well as prognosis (short-term mortality by determining theoutcome on the 7th day of stroke, especially survivor and deceased; mean of Glasgow coma scale on day 1; mean of the Hemphill, WFNS, Fisher and Four scores during d1, d3 and d7) as well as prognosis (Glasgow, Hemphill, WFNS, Fisher and Four scores, established respectively at admission, d1, d3, and d7), short-term mortality (i.e. during the first 7 days of hospitalization).
Dosage of Plasmatic Neuroglobin
The Ngb was assayed using a previously parameterized automaton (Elisys Uno TM , Human®, Germany) using the ELISA technique. To do this, an Elabscience® KIT ELISA kit was used. The assay technique used in this study was previously described in the user manual provided by Elabscience® [49] . To begin with, 100 microliters of serum was placed in the wells containing the anti-Ngb monoclonal 
Statistical Analysis
This investigation used a convenience sample. The study population consisted of 
Results
Of the 69 recruited, including 39 suspected stroke and 30 controls, there were 47 World Journal of Neuroscience men and 22 women (ratio M/W = 2.13). The epidemiological and clinical parameters, the stroke type's, the intracerebral hematoma volume, as well as the CmNgb of the 39 persons victims for stroke are summarized in Table 1 .
Men accounted for 72.80% (n = 28/39), while 28.20% (n = 11/39) were women. The mean of age of the stroke population was 49 ± 12.5 years [18] - [63] . Of the 39 suspected strokes, 25 were found to have arterial hypertension (64.10%), while 23 (59%) arrived at the hospital during the first 6 hours after the delay presumed occurrence of the first symptoms of stroke. For vital parameters, the mean of Glasgow coma scale was 13 ± 1.20 [3] - [15] . were before the 5th day, including 7 ICH and 2 SAH (Table 1) . From a brain scan point of view, with regard to the types of stroke, ICH's were found in 53.90% of cases (n = 21/39), followed by CI's with n = 13/39 (33.30%), and SAH in 12.80% of cases (n = 5/39). Moreover, in ICH patients, intracerebral hematoma volumes greater than 30 cm 3 were noted in 9 patients, that is to say 42.85% (n = 9/21) ( Table 2) . For biological data, the mean of concentration of plasma neuroglobin (CmNgb) of the general population was 1.400 ± 1.670 ng/ml. In controls, it was 0.303 ± 0.114 ng/ml, compared to 3.140 ± 2.700 ng/ml for stroke victims of all types. Of the 21 patients who presented ICH, n = 10/21 (47.64%) had an ICH score ≥ 2/6. In CI victim's, 76.90% (n = 10/13) had a Four score ≥ 15/16 ( Table 2 ).
The comparison of the CmNgb of stroke victims with that of the controls at admission, its evolution over time as well as its relation with the epidemiological and clinical parameters including age, sex, history of arterial hypertension, the delay in the presumed occurrence of the initial symptoms of stroke, the Glasgow coma scale as well as the prognosis in the first week of admission, and the volume of intracerebral hematoma had been studied by the Spearman, Mann-Whitney and Wilcoxon tests.
Data from this analysis show that in controls, no relationship was found between CmNgb and age (p = 0.070), sex (1.020 ± 1.810 ng/ml in men, and 1.300 ± 1.200 ng/ml in women, p = 0.975). In addition, there was no relationship between the existence of the history of arterial hypertension and CmNgb in patients (p = 0.975). At the same time, there was a relationship between CmNgb collected from admission in subjects with stroke of any type, and the delay presumed occurrence of the first symptoms of stroke, especially, occurrence before the 6th hour, or after 6th hour following hospitalization (0.643 ± 0.244 ng/ml before 6 h, against 3.140 ± 2.700 ng/ml after 6 h, p = 0.003). Regarding the comparison of CmNgb between CI and ICH at hospitalization, it was 5.805 ± 0.720 ng/ml in CI and 1.750 ± 0.090 ng/ml in ICH (p = 0.03) ( Table 2) . About brain imaging, there is a relationship between the CmNgb and the volume of the hematoma. In fact, CmNgb was 2.161 ± 0.375 ng/ml for hematomas with a volume greater than 30 mm 3 , compared with 1.210 ± 0.752 ng/ml for those with a lower volume (p = 0.0027).
There was no relationship between CmNgb, mean of Glasgow coma scale (p = 0.427) and outcome of patients during the first week of hospitalization (p = 0.06) ( Table 2 ).
The study of the kinetics of CmNgb according to the type of stroke reveals that it was higher on d1 in the subjects with CI (5.805 ± 0.720 ng/ml) than ICH (1.750 ± 0.090 ng/ml) (p = 0.003). At d3, it was 2.602 ± 0.112 ng/ml for CI and 0.420 ± 0.211 for ICH. At the 7th day of hospitalization, it was 0.420 ± 0.20 ng/ml (p = 0.001) in the victims of CI, compared to 0.360 ± 0.300 ng/ml in the ICH (p = 0.002) ( Table 3) . 
Discussion
Limitations of Work
The purpose of this prospective study was to evaluate the role of plasma Ngb in the initial diagnosis and short-term prognosis of adult stroke victims (infarction and hemorrhage), taking into account subgroups (CI or cerebral infarction, SHA or subarachnoid haemorrhage, ICH or intracerebral hematoma). To do this, we selected a convenience sample, consisting of stroke suspects (patients), selected consecutively over a one-year period, with direct match by age and sex to persons in good health (Volunteers). This investigation being a hospital series, we unfortunately ran into several difficulty. The most frequent were the difficulty of obtaining a brain scan (economical difficults, disponibility of imaging), before taking blood samples, the use of drugs that can modify the expression of Ngb by some clinicians [43] , a significant number of refusals of consent, lost to follow-up, and to a lesser degree, the loss of some samples. These different facts resulted in reduced sample size, which inevitably impacted the composition of stroke subgroups. However, despite these limitations, our data show that in the acute phase of stroke, compared to controls, the plasma concentration of neuroglobin (CmNgb) increases significantly regardless of the type of stroke (ICH or CI). Moreover, this increase is greater in the case of ischemia than hemorrhage, and seems to follow a triphasic kinetics. Conversely, no relationship was found between Glasgow coma scale, short-term mortality and CmNgb. Similarly, we could not analyze the relationships between CmNgb and specific prognostic scores for stroke, particularly because of the size of the sample. In all cases, according to the other human studies of Ngb's expression during nervous system diseases, our data seem to support the idea that Ngb is overexpressed during hypoxic- [54] . Thus, our results suggest that, in human, plasma neuroglobin can be used as a bio-marker for initial diagnosis, but not for the short-term prognosis of acute adult stroke.
Epidemiological and Clinical Parameters of the General Population, Stroke Subjects as well as Subgroups (CI and ICH)
In our series, we noted more hemorrhagic than ischemic strokes (26 versus 13). These data are similar to those obtained by Adeloye et al. [28] , Burgnicourt et al. World Journal of Neuroscience [29] , Ovbiagel et al. [31] , and Eyang Biyoghe et al. [30] . However, other authors have found more CI than ICH [32] . These results could be explained by the existence of African populations, an arterial hypertension usually of early discovery, often poorly controlled, related to the male sex, geo ethnic and genetic fac- Concerning the gender, men presented more hypertension than women. According to African studies, this result corroborates those found by several other authors [28] - [33] . This male predominance may be explained by the high frequency of some risk factors in men [28] [29] [31] . In contrast, the low prevalence observed in women is thought to be related to the hormonal cycle [55] [56].
The mean age of the stroke population in this investigation is relatively similar to that of the majority of African studies, with a peak frequency of ICH in younger people, one of the reasons of which would be early hyperten- However, this control CmNgb is not identical to that found by other authors.
Comparison of CmNgb between Stroke Victims and Controls
Indeed, in animals, Shang et al. [12] had conducted a study examining the dy- 
CmNgb and Mean of Age of the Working Population
This study found no relationship between CmNgb and age, both in patients and controls (p = 0.07). Concerning the CmNgb and age, Sun et al. [61] Contrary at the study of Szymanski et al. [62] who showed that the expression of Ngb was relatively lower in female subjects compared to males, we found no statistically significant difference between men and women, both in controls and in stroke (1.020 ng/ml versus 1.300 ng/ml, p = 0.975). One of the hypotheses that could explain the difference between our results and Szymanski's results would be methodological. Indeed, we have registered more men than women (ratio M/W = 2.5). Another reason is that, unlike our work, which treat with stroke victims, Szymanski et al's research mainly treat with adult subjects suffering from Alzheimer's disease, whose onset is in part generally correlated with neurodegeneration, life experance and female sex [62] .  Comparison of stroke neuroglobinemia to that of controls At the end of the present investigation, it was found that in comparison with the controls, the CmNgb of stroke victims was higher regardless of the type (ischemic or hemorrhagic) (p = 0.07). Stroke usually results from rupture (hemorrhage) or vascular obstruction (ischemia) which are responsible to the hypo infusion, hypoxia and cellular ischemia. These latter processes are themselves responsible for inflammation and cellular suffering [34] [11] . Thus, the secondary occurrence of the cascade of events responsible for the Ngb brain expression (hypoxia, ischemia, apoptosis) during ICH compared to the CI (immediatly ischemia, no secondary occurrence) could explain the observed difference between the two groups. Therefore, like other biomarkers of stroke, CmNgb could be used as a diagnostic marker, differentiating ischemia from haemorrhage [38] [39] [40] [41]. Better still, in clinical practice, CmNgb would be used to differentiate, for example, ICH from intra cerebral hematoma resulting from hemorrhagic transformation of an ischemic stroke.  Comparison of CmNgb taken on admission and the presumed time of appearance to first stroke symptoms in patients We found a statistically significant relationship between the level of Ngb taken from admission in stroke and the presumed time of appearance to the first symptoms of the disease (0.643 ng/ml before 6 h, against 3.140 ng/ml after 6 h, p = 0.003). In other terms, CmNgb varied with duration of stroke. This result is comparable to that of other authors [11] [12] [13] [27] [51] [53] . He would correspond to a progressive production of the Ngb, and a fall of the latter, after a peak of production. Thus, despite the fact that we have not been able to monitor the CmNgb early (that is to say from the installation of the initial symptomatology until admission to the service), our results support the idea that elevation of CmNgb is a function of the duration of stroke [11] [53] . This elevation of Ngb in the acute phase of stroke may be explained by the ischemic nature of the initial lesion and/or because stroke (ischemic or hemorrhagic) is usually complicated by initial or secondary cerebral ischemia, with cell lysis, favoring the progressive overexpression of Ngb at the cerebral level and secondarily the release in the plasma [24] Indeed, these authors suggested that the increase of Ngb was inversely proportional to the size of the ischemic lesions in the rodent. These contradictory re-  Relationship between the prognostic scores of stroke and CmNgb collected on admission in stroke subjects There was no relationship between Glasgow coma scale at the admission in stroke and the CmNgb (p = 0.427). The Glasgow coma scale assesses the level of consciousness in comatose patients, without presaging etiology [44] . Moreover, when it is performed on admission, it contributes to the establishment of the neurological prognosis of the patient. In this case, our results might suggest that the Ngb has no prognostic interest and would still allow less to assess the state of consciousness. However, this score is not very specific and not very sensitive in the context of the strokes, from where besides the setting of specific scores by many authors [45] [46] [47] [48] . In this case, another explanation for the absence of relationship of this score with the CmNgb is the fact of its low sensitivity and specificity during stroke [45] [46] [47] [48] . Finally, the weakness of the sample size of patients with a low Glasgow score would also be a reason.
At the same time, probably because of the size of the sample, no relationship could be analyzed between the specific gravity scores of the stroke (ICH Hemphill score for intracerebral hematoma, WFNS and Fisher scores for SAH, FOUR score for CI) and CmNgb. Thus, in the African context, a study of Ngb variation in hemorrhagic stroke involving a large sample of patients and taking into account subgroups of ICH is desirable.  CmNgb and short-term mortality in stroke It has not been found none relationship between Ngb on admission and short-term mortality (p = 0.06). However, it was noted that, although the difference was not statistically significant, patients who survived had higher plasmatic Ngb concentration compared to those who died (3.95 ng/ml versus 2.65 ng/ml).
Despite the fact that current studies on Ngb are not specifically focused on mortality, some authors have found that Ngb overexpression is associated with im-World Journal of Neuroscience proved ischemic injury and functional recovery in rodents [1] 
Kinetics of CmNgb Collected at d1, d3 and d7 in CI and ICH Patients
Regarding the specific kinetics of Ngb as a function of the evolution of stroke, it was noted that the CmNgb, after an elevation phase, was reduced by half to d3 and became almost normal on d7, whatever the type of stroke. In the case of cerebral infarctions, this kinetics of Ngb was also found by Shang et al. in 2006 [14] . However, in this study, the concentration of Ngb was still significantly elevated at 72 h (11.94 ng/ml versus 2.60 ng/ml for this study). This could be explained by the fact that these studies were conducted in rats and not humans. In addition, methodologically, rodent experimentation consisted of bilateral carotid occlusion for 20 minutes, resulting in more lesions than under physiological conditions. Another explanation would be that our patients were mostly hypertensive and were receiving rheological treatment to prevent ischemia from increasing.
Regarding to ICH, the same triphasic kinetics was noted by Dongsheng et al. [50] , as well as Wei-de et al. [51] . According to the latter, this over expression would pathophysiologically reflect the secondary ischemia occurring in the peri-hematoma zone, and confirm the neuroprotective role of Ngb during the immediate phase of neuronal injury during ICH [50] [27] . In our opinion, this result suggests that plasma neuroglobin may play a role as a biomarker for early monitoring during the acute phase of stroke.
Conclusion
The present prospective study was designed to assess the role of plasma Ngb in the initial diagnosis and short-term prognosis of adult stroke victims. It emerges that, at the acute phase of a stroke, in comparison with that of controls, CmNgb increases significantly regardless of the type (ICH or CI). Moreover, this increase is greater in the case of ischemia than hemorrhage, and has a triphasic kinetics. In contrast, no relationship was found between the Glasgow coma scale, short-term mortality and CmNgb. In addition, no relationship could be analyzed between CmNgb and the usual prognostic scores of stroke subgroups. Thus, our results suggest that in human, neuroglobin plasmatic can be used as a diagnostic, but not prognostic biomarker for stroke in adults at the acute phase. However, this work needs to be confirmed on a larger sample of stroke taking into account the different subgroups.
